Catadegbrutinib (BGB-16673) Storage
Catadegbrutinib (BGB-16673) is inherently stable. We confirmed that it retains full structural integrity and biological activity under the following conditions
| 4°C | in DMSO | 3 days |
| -20°C | in DMSO | 1 month |
| -80°C | in DMSO | 1 year |
| -20°C | Powder | 3 years |
Catadegbrutinib (BGB-16673) Stability
Catadegbrutinib (BGB-16673) has been characterized over a three-year period for both purity and solubility.